| Title |
Author |
Type |
Date |
Words |
| Highest number for drug trials. |
|
|
Mar 30, 2021 |
275 |
| Roche Reports Updated Data For Tecentriq In Combination With Avastin. |
|
|
Jan 12, 2021 |
211 |
| Everolimus-eluting bioresorbable coronary scaffold in Asian patients: A 2-year follow-up. |
Azad, Muhammad Abdul Salam; Gul, Uzma; Javed, Asim |
Report |
Dec 31, 2020 |
2404 |
| Roche Secures European Approval For Tecentriq As Liver Cancer Drug. |
|
|
Nov 2, 2020 |
192 |
| COMPARISON OF EFFICACY OF CELECOXIB(SELECTIVE NON STEROIDAL ANTI INFLAMMATORY DRUG) VERSUS NAPROXEN(NON SELECTIVE NON STEROIDAL ANTI INFLAMMATORY DRUG) FOR POST ENDODONTIC PAIN. |
Beenish Abbas, Sana Abbas, Madiha Sattar, Shoaib Rahim and Sidra Amir |
|
Aug 31, 2020 |
2745 |
| OKYO Pharma lands world renowned scientist Dr Napoleone Ferrara, the inventor of blockbusters Avastin and Lucentis. |
|
|
Aug 20, 2020 |
448 |
| FDA Approves Monjuvi in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma. |
|
|
Aug 3, 2020 |
363 |
| MorphoSys And Incyte Celebrate US Green Light For Blood Cancer Drug. |
|
|
Aug 3, 2020 |
151 |
| MorphoSys announces FDA approval of Monjuvi, Lenalidomide combo. |
|
|
Aug 2, 2020 |
223 |
| Genentech says Phase III IMagyn050 study did not meet primary endpoint. |
|
|
Jul 13, 2020 |
203 |
| Employment of Alginate Floating In Situ Gel for Controlled Delivery of Celecoxib: Solubilization and Formulation Studies. |
Rasool, Bazigha K. Abdul; Khalifa, AlZahraa; Abu-Gharbieh, Eman; Khan, Rawoof |
|
Jun 30, 2020 |
7204 |
| Low Dose of Genistein Alleviates Mono-(2-Ethylhexyl) Phthalate-Induced Fetal Testis Disorder Based on Organ Culture Model. |
Zhang, Tong-Dian; Ma, Yu-Bo; Li, He-Cheng; Chong, Tie; Wang, Zi-Ming; Zhang, Lian-Dong |
|
Jun 30, 2020 |
6997 |
| A Simple and Rapid LC-MS/MS Method for Therapeutic Drug Monitoring of Lenalidomide. |
Neset Nesetoglu, Cem Kaplan, Serap Saglik Aslan and Durisehvar Ozer Unal |
|
Jun 30, 2020 |
3465 |
| Genistein-Induced Apoptosis Affects Human Telomerase Reverse Transcriptase Activity in Acute Promyelocytic Leukemia. |
Okcanoglu, Tugce Balci; Avci, Cigir Biray; Susluer, Sunde Yilmaz; Kayabasi, Cagla; Saydam, Guray; Gu |
|
Jun 1, 2020 |
2499 |
| FDA approves Genentech's Tecentriq in combination with Avastin. |
|
|
May 29, 2020 |
222 |
| A Liver Transplant Patient on Everolimus Treatment Presented with Acute Anterior Myocardial Infarction: Does the Type of Drug-eluting Stent Matter? |
Gurdogan, Muhammet; Yalta, Kenan; Yilmaztepe, Mustafa Adem; Altay, Servet; Akkus, Omer Ferudun |
Letter to the editor |
May 28, 2020 |
750 |
| A Simple and Rapid LC-MS/MS Method for Quantification of Total Daidzein, Genistein, and Equol in Human Urine. |
Saha, Shikha; Kroon, Paul A. |
|
Mar 1, 2020 |
6269 |
| Protective Effect of Genistein on Condylar Cartilage through Downregulating NF-[kappa]B Expression in Experimentally Created Osteoarthritis Rats. |
Yuan, Jian; Ding, Wanghui; Wu, Na; Jiang, Shijie; Li, Wen |
|
Mar 1, 2020 |
3996 |
| Oral Exposure to Genistein during Conception and Lactation Period Affects the Testicular Development of Male Offspring Mice. |
Shi, Zhicheng; Lv, Zengpeng; Hu, Chenhui; Zhang, Qing; Wang, Zhe; Hamdard, Enayatullah; Dai, Hongjia |
Report |
Mar 1, 2020 |
7716 |
| Suppressive Effects of GSS on Lipopolysaccharide-Induced Endothelial Cell Injury and ALI via TNF-[alpha] and IL-6. |
Yi, Lei; Zhou, Zengding; Zheng, Yijuan; Chang, Mengling; Huang, Xiaoqin; Guo, Feng; Zhao, Quanming; |
|
Jan 1, 2020 |
7048 |
| Development of UV Spectrophotometric Procedures for Determination of Amlodipine and Celecoxib in Formulation: Use of Scaling Factor to Improve the Sensitivity. |
Attimarad, Mahesh; Venugopala, Katharigatta Narayanaswamy; Aldhubiab, Bandar E.; Nair, Anroop Balach |
|
Dec 31, 2019 |
6419 |
| RNA Expression Profile and Alternative Splicing Signatures of Genistein-Treated Breeder Hens Revealed by Hepatic Transcriptomic Analysis. |
Lv, Zengpeng; Jiang, Jingle; Ning, Chao; Dai, Hongjian; Jin, Song; Wei, Xihui; Yu, Debing; Shi, Fang |
|
Dec 31, 2019 |
9845 |
| Corrigendum to "Serial Changes of Neointimal Tissue after Everolimus-Eluting Stent Implantation in Porcine Coronary Artery: An Optical Coherence Tomography Analysis". |
|
Correction notice |
Dec 31, 2019 |
297 |
| Case of Stroke from Cerebral Vasculitis following Carfilzomib, Lenalidomide, and Dexamethasone Therapy in a Patient with Relapsing Multiple Myeloma. |
Osafehinti, Deborah; Zivari, Kaveh |
|
Dec 31, 2019 |
1749 |
| Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status. |
Yui, Kunio; Imataka, George; Sasaki, Hitomi; Kawasaki, Yohei; Okanshi, Tohru; Shiroki, Ryoichi; Yosh |
|
Dec 31, 2019 |
6845 |
| Starton Successfully Completes Proof of Concept Study for Transdermal Lenalidomide. |
|
|
Dec 27, 2019 |
853 |
| Development of an In Vivo Lipopolysaccharide Inflammation Model to Study the Pharmacodynamics of COX-2 Inhibitors Celecoxib, Mavacoxib, and Meloxicam in Cockatiels (Nymphicus hollandicus). |
Gasthuys, Elke; Houben, Renee; Haesendonck, Roel; De Baere, Siegrid; Sys, Stanislas U.; Morrens, Joa |
|
Dec 1, 2019 |
8365 |
| Janssen Receives EU Marketing Authorisation for Darzalex in Combination with Lenalidomide and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible. |
|
|
Nov 21, 2019 |
601 |
| Lenalidomide Delays Progression in Smoldering Multiple Myeloma; Progression-free survival significantly longer with lenalidomide compared with observation. |
|
|
Nov 7, 2019 |
282 |
| Roche's Tecentriq In Combination With Avastin Improves Survival. |
|
|
Oct 21, 2019 |
199 |
| Genentech says Phase III IMbrave150 study met co-primary endpoints. |
|
|
Oct 21, 2019 |
226 |
| Corrigendum to "Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features". |
|
Correction notice |
Aug 31, 2019 |
158 |
| China Recombinant Human Endostatin Investigation Market Report, 2019-2023. |
|
Report |
Aug 23, 2019 |
589 |
| Sunitinib Malate Market Research Report Overview, Scope, Top Manufacturers, and Forecast to 2025. |
|
Report |
Jul 23, 2019 |
892 |
| Do Not Ban Avastin, An Intraocular Injection -OSN. |
|
|
Jul 11, 2019 |
593 |
| Johnson & Johnson (NYSE: JNJ) - Janssen Announces U.S. FDA Approval of DARZALEX[R] (daratumumab) in Combination with Lenalidomide and Dexamethasone for Newly Diagnosed Patients with Multiple Myeloma Who Are Transplant Ineligible -- 27/6/2019. |
|
|
Jul 4, 2019 |
492 |
| Preparation and Evaluation of Inflammation Targeted Nano-micellar Formulation of Celecoxib. |
Bahadori, Fatemeh; Buyuk, Ayse Smyrna; Kozanoglu, Ahmed Serdar; Eskandari, Zahra; Ankarali, Handan; |
|
Jul 1, 2019 |
4256 |
| Erratum to "Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac". |
Walker, Chris |
Correction notice |
Jun 30, 2019 |
152 |
| Celgene Corporation (NASDAQ: CELG) - FDA Approves REV LI MID[R] (Lenalidomide) In Combination With Rituximab For the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma -- 28/5/2019. |
|
|
May 29, 2019 |
622 |
| US Food and Drug Administration grants approval to Pfizer's Fragmin injection. |
|
|
May 20, 2019 |
185 |
| US Food and Drug Administration grants approval to Pfizer's Fragmin injection. |
|
|
May 20, 2019 |
189 |
| Supplementing Genistein for Breeder Hens Alters the Fatty Acid Metabolism and Growth Performance of Offsprings by Epigenetic Modification. |
Lv, Zengpeng; Fan, Hao; Song, Bochen; Li, Guang; Liu, Dan; Guo, Yuming |
|
Apr 30, 2019 |
10920 |
| Dietary Genistein Could Modulate Hypothalamic Circadian Entrainment, Reduce Body Weight, and Improve Glucose and Lipid Metabolism in Female Mice. |
Zhou, Liyuan; Xiao, Xinhua; Zhang, Qian; Zheng, Jia; Li, Ming; Yu, Miao; Wang, Xiaojing; Deng, Mingq |
|
Apr 30, 2019 |
6856 |
| Formononetin Enhances the Tumoricidal Effect of Everolimus in Breast Cancer MDA-MB-468 Cells by Suppressing the mTOR Pathway. |
Zhou, Qianmei; Zhang, Weihong; Li, Tian; Tang, Runwei; Li, Chaoran; Yuan, Shuai; Fan, Desheng |
|
Apr 30, 2019 |
3587 |
| A Case of Everolimus Related Pneumonitis Occurred After Switching Treatment from Sirolimus in a Kidney Transplant Patient/Tedavinin Sirolimus'tan Everolimus'a degistirilmesi sonucu Everolimus'a bagli pnomonit gelisen bir bobrek transplantasyonu hastasi olgusu. |
Kaya, Eda; Karakoc, Alican; Velidedeoglu, Mehmet; Pekmezci, Salih; Trabulus, Sinan; Seyahi, Nurhan |
|
Apr 1, 2019 |
1593 |
| Cytomegalovirus Retinitis Associated with Lenalidomide Use for Multiple Myeloma in an Immunocompetent Patient. |
Adams, Matthew K.; Weng, Christina Y. |
|
Mar 31, 2019 |
1907 |
| Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation. |
Grager, Nikolai; Leffler, Mareike; Gottlieb, Jens; Fuge, Jan; Warnecke, Gregor; Gutzmer, Ralf; Satzg |
|
Mar 31, 2019 |
7991 |
| Cancer patient is denied 'vital' drug because she lives wrong side of border. |
|
|
Mar 19, 2019 |
633 |
| Cancer patient denied 'vital' drug because she lives half a mile wrong side of border. |
|
|
Mar 18, 2019 |
627 |
| Terminally ill cancer patient denied life-prolonging drug because she lives HALF A MILE over the border; Joannah Houghton, who gets chemotherapy treatment at Clatterbridge Cancer Centre in Wirral, misses out on Avastin by a journey of just three minutes. |
|
|
Mar 17, 2019 |
749 |
| Pfizer Receives European Approval for Zirabev, a Biosimilar to Avastin. |
|
|
Feb 21, 2019 |
250 |
| Pfizer reports European approval for biosimilar to Avastin. |
|
|
Feb 19, 2019 |
118 |
| Roche says CHMP recommends EU approval of Tecentriq in combination with Avastin. |
|
|
Feb 1, 2019 |
144 |
| FDA Approves Genentech's Tecentriq in Combination with Avastin and Chemotherapy for the Initial Treatment of People with a Specific Type of Metastatic Lung Cancer. |
|
|
Dec 11, 2018 |
624 |
| Premature Bebeklerde Retinopati Gelisimine Etki Eden Risk Faktorlerinin Degerlendirilmesi/Evaluation of Risk Factors Affecting Development of Retinopathy in Premature Infants. |
Gul, Filiz; Bulbul, Ali |
Report |
Dec 1, 2018 |
4483 |
| WET AMD DRUG RULING. |
|
Brief article |
Nov 1, 2018 |
149 |
| Application of Lenalidomide on Diffused Large B-cell Lymphoma: Salvage, Maintenance, and Induction Treatment. |
Ma, Li-Yangxue; Su, Li |
Report |
Oct 20, 2018 |
2492 |
| A PS1.3 million victory for common sense. |
|
|
Oct 4, 2018 |
703 |
| Health leaders cheer High Court victory for cheaper eye treatment; Case was brought by pharmaceutical giants Bayer and Novartis against 12 CCGs - including Stockton and Hartlepool. |
|
|
Sep 28, 2018 |
708 |
| NHS legal win in big pharma drugs battle. |
|
|
Sep 22, 2018 |
118 |
| Leiters to ship new repackaged Avastin under US FDA 2018 guidance. |
|
|
Sep 20, 2018 |
214 |
| Leiters to ship new repackaged Avastin under US FDA 2018 guidance. |
|
|
Sep 20, 2018 |
210 |
| Rituximab + Lenalidomide Effective in Follicular Lymphoma; Response rate, progression-free survival comparable to those seen with rituximab-chemotherapy. |
|
|
Sep 11, 2018 |
248 |
| Effects of Two-by-Two Combination Therapy with Valproic Acid, Lithium Chloride, and Celecoxib on the Angiogenesis of the Chicken Chorioallantoic Membrane. |
Afzal, Ehsan; Alinezhad, Sedigheh; Khorsand, Marjan; Khoshnood, Mohammad Javad; Takhshid, Mohammad A |
|
Sep 1, 2018 |
4220 |
| JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer. |
|
|
Aug 31, 2018 |
476 |
| Genistein Improves Liver Damage in Male Mice Exposed to Morphine. |
Salahshoor, Mohammad; Roshankhah, Shiva; Hosseni, Payman; Jalili, Cyrus |
Report |
Jul 5, 2018 |
5149 |
| CORRELATION OF INTRAOCULAR PRESSURE WITH OCULAR AXIAL LENGTH AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB IN DIABETIC MACULAR EDEMA. |
|
Report |
Jun 30, 2018 |
3237 |
| Roche receives USFDA approval for Avastin. |
|
|
Jun 15, 2018 |
136 |
| Roche receives USFDA approval for Avastin. |
|
|
Jun 15, 2018 |
132 |
| Genentech says FDA approves Avastin plus chemotherapy in ovarian cancer. |
|
|
Jun 13, 2018 |
262 |
| FDA approves Genentech's Avastin plus chemo for ovarian cancer treatment. |
|
|
Jun 13, 2018 |
152 |
| Adjunctive Everolimus Therapy for Treatment-resistant Focal-onset Seizures Associated with Tuberous Sclerosis: A Phase 3, Randomised, Double-blind, Placebo-controlled Study/Tuberoskleroz ile Iliskili, Tedaviye Direncli Fokal Baslangicli Nobetler icin Yardimci Everolimus Tedavisi: 3 Asamali, Randomize, Cift Kor, Plasebo Kontrollu Calisma. |
Karaoglan, Mustafa |
Report |
Jun 1, 2018 |
784 |
| Short term clinical outcomes of Everolimus-eluting stents in patients with stable angina pectoris. |
|
Report |
Apr 30, 2018 |
3094 |
| Role of intravitreal bevacizumab in management of Eale's Disease. |
|
|
Apr 30, 2018 |
3499 |
| FDA to hold a joint committee meeting. |
|
|
Apr 24, 2018 |
101 |
| Celecoxib Lowers Opioid Use Post Head & Neck Cancer Surgery; Decreased opioid use seen after head and neck cancer surgery with free tissue reconstruction. |
|
|
Apr 23, 2018 |
242 |
| Neonatal Genistein Exposure and Glucocorticoid Signaling in the Adult Mouse Uterus. |
Whirledge, Shannon D.; Kisanga, Edwina P.; Oakley, Robert H.; Cidlowski, John A. |
Report |
Apr 1, 2018 |
12057 |
| Roche's phase III lung cancer study of Tecentriq combined with Avastin indicates clinically significant survival benefit. |
|
|
Mar 27, 2018 |
258 |
| Roche's phase III lung cancer study of Tecentriq combined with Avastin indicates clinically significant survival benefit. |
|
|
Mar 27, 2018 |
254 |
| Genentech Study Shows Addition of Tecentriq to Avastin /Carboplatin / Paclitaxel Extends Lifetime of People with Advanced Lung Cancer. |
|
|
Mar 27, 2018 |
399 |
| Genentech says Phase III IMpower150 study met co-primary endpoint. |
|
|
Mar 26, 2018 |
122 |
| Roche issues challenge to Bristol, Merck cancer drugs with Tecentriq cocktail. |
|
|
Mar 26, 2018 |
349 |
| Pars plana vitrectomy in vitreous hemorrhage with or without Intravitreal Bevacizumab: A comparative overview. |
|
Report |
Feb 28, 2018 |
3443 |
| Roche's Tecentriq and Avastin combination decreases risk of disease worsening or death in Phase III cancer study. |
|
|
Feb 8, 2018 |
193 |
| Roche's Tecentriq and Avastin combination decreases risk of disease worsening or death in Phase III cancer study. |
|
|
Feb 8, 2018 |
189 |
| Roche IMmotion 151 phase 3 study saw TECENTRIQ and Avastin reduced KD risk. |
|
|
Feb 5, 2018 |
255 |
| WET AMD DRUG DISPUTE. |
|
|
Feb 1, 2018 |
454 |
| Amgen and Allergan's MVASI (Biosimilar Bevacizumab) Approved by European Commission for Treatment of Certain Cancers. |
|
|
Jan 24, 2018 |
362 |
| Amgen & Allergan's MVASI (Biosimilar Bevacizumab) approved by EC for certain types of cancer. |
|
|
Jan 19, 2018 |
296 |
| Amgen & Allergan's MVASI (Biosimilar Bevacizumab) approved by EC for certain types of cancer. |
|
|
Jan 19, 2018 |
300 |
| CCGs facing legal dispute over use of cancer drug as wet AMD treatment option. |
|
|
Jan 9, 2018 |
636 |
| CCGs facing legal dispute over use of cancer drug as wet AMD treatment option. |
|
|
Jan 9, 2018 |
640 |
| Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer. |
Yang, R.F.; Yu, B.; Zhang, R.Q.; Wang, X.H.; Li, C.; Wang, P.; Zhang, Y.; Han, B.; Gao, X.X.; Zhang, |
Report |
Jan 1, 2018 |
5456 |
| Modulation of Adipocyte Differentiation and Proadipogenic Gene Expression by Sulforaphane, Genistein, and Docosahexaenoic Acid as a First Step to Counteract Obesity. |
Valli, Veronica; Heilmann, Katharina; Danesi, Francesca; Bordoni, Alessandra; Gerhauser, Clarissa |
|
Jan 1, 2018 |
4491 |
| Synthesis, Characterization, and Biodistribution of Quantum Dot-Celecoxib Conjugate in Mouse Paw Edema Model. |
Kalangi, Suresh K.; Swarnakar, Nitin K.; Sathyavathi, R.; Rao, D. Narayana; Jain, Sanyog; Reddanna, |
|
Jan 1, 2018 |
4952 |
| Thrombotic Thrombocytopenic Purpura Associated with Pazopanib. |
Syed, Umer; Wahlberg, Kramer J.; Douce, Daniel R.; Sprague, Julian R. |
|
Jan 1, 2018 |
1493 |
| Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features. |
Khan, Abdullah M.; Muzaffar, Jameel; Murthy, Hermant; Wingard, John R.; Moreb, Jan S. |
|
Jan 1, 2018 |
4143 |
| Preemptive Analgesia in Total Knee Arthroplasty: Comparing the Effects of Single Dose Combining Celecoxib with Pregabalin and Repetition Dose Combining Celecoxib with Pregabalin: Double-Blind Controlled Clinical Trial. |
Lubis, Andri M.T.; Rawung, Rangga B.V.; Tantri, Aida R. |
|
Jan 1, 2018 |
4215 |
| Lenalidomide and Low Dose Dexamethasone Plus Elotuzumab or Carfilzomib for Relapsed or Refractory Multiple Myeloma: A Comparison of Progression-Free Survival with Reconstructed Individual Participant Data. |
Li, Shuo; Meng, Xiang-Yu; Maman, Souraka Tapara Dramani; Xiao, Yong-Nong; Li, Sheng |
|
Jan 1, 2018 |
3952 |
| An Interesting Case and Literature Review of a Coronary Stent Fracture in a Current Generation Platinum Chromium Everolimus-Eluting Stent. |
Aung, Sammy San Myint; Latt, Htun; Kyaw, Kyaw; Roongsritong, Chanwit |
|
Jan 1, 2018 |
2326 |
| Synthesis, Characterization, and Antioxidant Activities of Genistein, Biochanin A, and Their Analogues. |
Sherif, Salah Hamza; Gebreyohannes, BerihuTekluu |
|
Jan 1, 2018 |
4782 |
| A Case of Chemotherapy-Refractory "THRLBCL like Transformation of NLPHL" Successfully Treated with Lenalidomide. |
Siricilla, Mamatha; Irwin, Lydia; Ferber, Andres |
|
Jan 1, 2018 |
4962 |
| Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient. |
Patel, Serena; Mendler, Michel H.; Valasek, Mark A.; Tsunoda, Shirley M. |
|
Jan 1, 2018 |
3619 |
| Refractive and Biometrie Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age. |
Chen, Yen-Chih; Chen, San-Ni; Yang, Benjamin Chi-Lan; Lee, Kun-Hsien; Chuang, Chih-Chun; Cheng, Chie |
Correction notice |
Jan 1, 2018 |
4240 |
| Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery. |
Zuo, Lei; Zhang, Jianhong; Xu, Xun |
|
Jan 1, 2018 |
7550 |
| Genistein Exposure Interferes with Pharmacokinetics of Celecoxib in SD Male Rats by UPLC-MS/MS. |
Zheng, Xiang; Wen, Jian; Liu, Teng-hui; Ou-yang, Qiu-Geng; Cai, Jian-ping; Zhou, Hong-yu |
|
Jan 1, 2018 |
3949 |
| Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac. |
Walker, Chris |
|
Jan 1, 2018 |
8781 |
| Roche's combination of Tecentriq and Avastin plus chemotherapy extends lung cancer patients' lives in Phase III study. |
|
|
Dec 11, 2017 |
178 |
| Roche's combination of Tecentriq and Avastin plus chemotherapy extends lung cancer patients' lives in Phase III study. |
|
|
Dec 11, 2017 |
182 |
| FDA Grants Genentech's Avastin Full Approval for Most Aggressive form of Brain Cancer. |
|
|
Dec 8, 2017 |
338 |
| Tecentriq and Avastin Plus Chemotherapy Doubles PFS Compared to Avastin Plus Chemo in Advanced NSCLC. |
|
|
Dec 8, 2017 |
415 |
| FDA grants full approval for Genentech's Avastin. |
|
|
Dec 5, 2017 |
155 |
| Genentech Study of Tecentriq (atezolizumab) and Avastin (bevacizumab) Plus Chemotherapy Meets Primary Endpoint of PFS in Advanced Non-squamous NSCLC. |
|
|
Nov 27, 2017 |
456 |
| FDA Grants Pfizer Approval of Sutent (sunitinib malate) as Adjuvant Treatment in Adults with High Risk of Recurrent RCC Following Nephrectomy. |
|
|
Nov 20, 2017 |
309 |
| Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. |
|
|
Nov 16, 2017 |
260 |
| Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. |
|
|
Nov 16, 2017 |
256 |
| Opdivo (nivolumab) Shows Three-Year Survival Benefit in Advanced RCC, Reducing Risk of Death by 26% versus Everolimus in CheckMate -025 study. |
|
|
Nov 7, 2017 |
409 |
| 'We cannot allow NHS to be held to ransom'. |
|
|
Nov 1, 2017 |
585 |
| Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma. |
Bukhari, Nedal |
Report |
Nov 1, 2017 |
1532 |
| US FDA receives Roche's supplemental biologics license application for Avastin. |
|
|
Oct 30, 2017 |
173 |
| US FDA receives Roche's supplemental biologics license application for Avastin. |
|
|
Oct 30, 2017 |
169 |
| FDA reviews Roche's Avastin as first-line treatment for ovarian cancer. |
|
|
Oct 27, 2017 |
227 |
| FDA reviews Roche's Avastin as first-line treatment for ovarian cancer. |
|
|
Oct 27, 2017 |
223 |
| FDA Grants Denovo Biopharma Permission to Proceed with Clinical Trial of DB102 (Enzastaurin) in Diffuse Large B Cell Lymphoma. |
|
|
Oct 25, 2017 |
259 |
| Women denied cancer drug. |
|
|
Sep 15, 2017 |
317 |
| Drug denied to cervical cancer patients INWALES. |
|
|
Sep 15, 2017 |
536 |
| Health services warn over counterfeit cancer drug sold in the north. |
|
|
Jul 14, 2017 |
262 |
| Angiogenesis and Tumor Progression Inhibition of Cyclooxygenase-2 Selective Inhibitor Celecoxib Associated with Poly (lactic-co-glycolic acid) in Tumor Cell Line Resistant to Chemotherapy/Inhibicion de Angiogenesis y Progresion Tumoral por Inhibidor Selectivo de Ciclooxigenasa-2 Celecoxib Asociado con Acido (poli lactico co-glicolico) en Linea de Celulas Tumorales Resistentes a Quimioterapia. |
Roa, Ignacio; Cantin, Mario; Vilos, Cristian; Rosas, Carlos; Lemus, David |
|
Jun 1, 2017 |
4380 |
| Dalteparin replacement of unfractionated heparin (UFH) for extracorporeal circuit (ECC) anticoagulation in an outpatient hemodialysis unit. |
Campbell, Lesley; Schneider, Maryann |
Brief article |
Apr 1, 2017 |
267 |
| Celecoxib scores ok on cardiac safety: a three-drug, 10-year trial found it equivalent, or "noninferior," to ibuprofen and naproxen. |
|
|
Mar 1, 2017 |
589 |
| IMPROVEMENT OF GROWTH PERFORMANCE AND INTESTINAL DIGESTIVE FUNCTION IN BROILER CHICKENS BY SUPPLEMENTATION OF SOY ISOFLAVONE IN CORN-SOY DIET. |
|
Report |
Feb 28, 2017 |
4228 |
| Genentech Touts Study Data for Tecentriq, Avastin Combo in Locally Advanced or Metastatic Renal Cell Carcinoma. |
|
|
Feb 22, 2017 |
682 |
| Tracon Pharmaceuticals' combination of TRC105 with Avastin fails to perform better than Avastin. |
|
|
Feb 14, 2017 |
199 |
| Tracon Pharmaceuticals' combination of TRC105 with Avastin fails to perform better than Avastin. |
|
|
Feb 14, 2017 |
195 |
| A clinical study on management of corneal neovascularisation to prevent Corneal transplant failure. |
Raman, Niraimozhi; Gnanaselvan, Helen Rosita |
Report |
Feb 13, 2017 |
2731 |
| Celgene Receives Positive CHMP Opinion to Expand Revlimid (Lenalidomide) Indication. |
|
|
Jan 27, 2017 |
571 |
| Ocular Adverse Effects of Intravitreal Bevacizumab Are Potentiated by Intermittent Hypoxia in a Rat Model of Oxygen-Induced Retinopathy. |
Tan, Jeffrey J.; Cai, Charles L.; Shrier, Eric M.; McNally, Lois; Lazzaro, Douglas R.; Aranda, Jacob |
|
Jan 1, 2017 |
8750 |
| Bevacizumab (Avastin) and Thermal Laser Combination Therapy for Peripapillary Choroidal Neovascular Membranes. |
Adrean, Sean D.; Grant, Scott; Chaili, Siyang |
Report |
Jan 1, 2017 |
2757 |
| Suppression of Retinal Neovascularization by Inhibition of Galectin-1 in a Murine Model of Oxygen-Induced Retinopathy. |
Yang, Ning; Zhang, Wenxi; He, Tao; Xing, Yiqiao |
Report |
Jan 1, 2017 |
4749 |
| Efficacy of Subconjunctival Bevacizumab Injections before and after Surgical Excision in Preventing Pterygium Recurrence. |
Nuzzi, Raffaele; Tridico, Federico |
Report |
Jan 1, 2017 |
4058 |
| Effect of Preoperative Intravitreal Bevacizumab on the Surgical Outcome of Neovascular Glaucoma at Different Stages. |
Kwon, Junki; Sung, Kyung Rim |
Report |
Jan 1, 2017 |
5683 |
| The CECARI Study: Everolimus (Certican[R]) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial. |
Van Keer, Jan; Derthoo, David; Van Caenegem, Olivier; de Pauw, Michel; Nellessen, Eric; Duerinckx, N |
|
Jan 1, 2017 |
5531 |
| Modeling of Tumor Growth Incorporating the Effects of Necrosis and the Effect of Bevacizumab. |
Drexler, Daniel Andras; Sapi, Johanna; Kovacs, Levente |
Report |
Jan 1, 2017 |
7532 |
| Design and Characterization of Endostatin-Loaded Nanoparticles for In Vitro Antiangiogenesis in Squamous Cell Carcinoma. |
Adeyemi, Samson A.; Choonara, Yahya E.; Kumar, Pradeep; du Toit, Lisa C.; Pillay, Viness |
|
Jan 1, 2017 |
9552 |
| Dietary Genistein Influences Number of Acetylcholine Receptors in Female Diabetic Jejunum. |
Schacht, Sydney; Masood, Faisal; Catmull, Shawn; Dolan, Robert; Altabtabaee, RussL; Grow, Wade; Nakk |
Report |
Jan 1, 2017 |
4960 |
| Everolimus Implicated in Case of Severe Gastrointestinal Hemorrhage. |
Gonzales, Paul; Klusewitz, Seth; Marowske, Johanna; Gancayco, John; Osswald, Michael B.; Setlik, Rob |
Clinical report |
Jan 1, 2017 |
2028 |
| Impact on Autophagy and Ultraviolet B Induced Responses of Treatment with the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and pp242 in Human Keratinocytes. |
Xu, Song; Li, Li; Li, Min; Zhang, Mengli; Ju, Mei; Chen, Xu; Gu, Heng |
Report |
Jan 1, 2017 |
11223 |
| Protective Effects of Genistein against Mono-(2-ethylhexyl) Phthalate-Induced Oxidative Damage in Prepubertal Sertoli Cells. |
Zhang, Liandong; Gao, Ming; Zhang, Tongdian; Chong, Tie; Wang, Ziming; Zhai, Xiaoqiang; Wu, Zhizhong |
Report |
Jan 1, 2017 |
6668 |
| Antiangiogenic Therapy for Diabetic Nephropathy. |
Tanabe, Katsuyuki; Maeshima, Yohei; Sato, Yasufumi; Wada, Jun |
Report |
Jan 1, 2017 |
9397 |
| The Phytoestrogen Genistein Produces Similar Effects as 17[beta]-Estradiol on Anxiety-Like Behavior in Rats at 12 Weeks after Ovariectomy. |
Rodriguez-Landa, Juan Francisco; Cueto-Escobedo, Jonathan; Puga-Olguin, Abraham; Rivadeneyra-Domingu |
Report |
Jan 1, 2017 |
7646 |
| Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System. |
Bai, Yongrui; Xu, Yuejuan; Wu, Bin |
Report |
Jan 1, 2017 |
4331 |
| Evaluation of Radiosensitizing and Anti-Angiogenesis Activity of Chelidonium majus Extract in Ehrlich Ascites Carcinoma Transplanted Mice. |
Hassan, Asmaa Abu-Bakr; Abdel-Rafei, Mohamed Khairy; Hasan, Hesham Farouk |
Report |
Dec 31, 2016 |
7093 |
| USFDA grants approval to Genentech's Avastin. |
|
|
Dec 8, 2016 |
146 |
| USFDA grants approval to Genentech's Avastin. |
|
|
Dec 8, 2016 |
142 |
| Amgen & Allergan partnership submits MAA to EMA for biosimilar candidate to Avastin (bevacizumab). |
|
|
Dec 5, 2016 |
256 |
| Role of bevacizumab in the prevention of early postoperative haemorrhage after 25-gauge microincision vitrectomy surgery. |
|
Report |
Oct 31, 2016 |
2800 |
| KTH takes lead in administering Avastin injection service to eye patients. |
|
|
Oct 10, 2016 |
618 |
| Efficacy and Safety of Zhuanggu Joint Capsules in Combination with Celecoxib in Knee Osteoarthritis: A Multi-center, Randomized, Double-blind, Double-dummy, and Parallel Controlled Trial. |
Zhang, Xian-Long; Yang, Jing; Yang, Liu; Liu, Jian-Guo; Cai, Xin-Yu; Fan, Wei-Ming; Yun, Xue-Qing; M |
Report |
Aug 1, 2016 |
3796 |
| Eisai Receives Positive CHMP Opinion on New Indication for Anticancer Agent Lenvatinib in Combination with Everolimus for Treatment of Advanced Renal Cell Carcinoma. |
|
|
Jul 22, 2016 |
1275 |
| Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017 - New Market Report. |
|
|
Jun 7, 2016 |
505 |
| Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis. |
Huang, Weihuan; Liang, Yeyin; Wang, Jiajian; Li, Guoqiang; Wang, Guocai; Li, Yaolan; Chung, Hau Yin |
Report |
Mar 15, 2016 |
5310 |
| Celecoxib/PLGA Suppresses Angiogenesis and Lung Metastasis of Murine Experimental Breast Cancer/ Celecoxib/PLGA Suprime Angiogenesis y Metastasis Pulmonar de un Cancer Mamario Murino Experimental. |
Roa, Ignacio; Cantin, Mario; Munoz, Mariela; Rosas, Carlos; Lemus, David |
|
Mar 1, 2016 |
4465 |
| Evaluation of the Isoflavone Genistein as Reversible Human Monoamine Oxidase-A and -B Inhibitor. |
Zarmouh, Najla O.; Messeha, Samia S.; Elshami, Faisel M.; Soliman, Karam F.A. |
|
Jan 1, 2016 |
7254 |
| Sex-Dependent Effects of Dietary Genistein on Echocardiography Profile and Cardiac GLUT4 Signaling in Mice. |
Leung, Lana; Martin, Joshua B.; Lawmaster, Todd; Arthur, Kathryn; Broderick, Tom L.; Al-Nakkash, Lay |
|
Jan 1, 2016 |
7293 |
| Propofol Suppressed Hypoxia/Reoxygenation-Induced Apoptosis in HBVSMC by Regulation of the Expression of Bcl-2, Bax, Caspase3, Kir6.1, and p-JNK. |
Zhang, Jianhai; Xia, Yunfei; Xu, Zifeng; Deng, Xiaoming |
|
Jan 1, 2016 |
5450 |
| Soy Isoflavone Protects Myocardial Ischemia/Reperfusion Injury through Increasing Endothelial Nitric Oxide Synthase and Decreasing Oxidative Stress in Ovariectomized Rats. |
|
|
Jan 1, 2016 |
7224 |
| Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-[beta] signaling pathway. |
Kim, Ye-Seul; Choi, Kyung-Chul; Hwang, Kyung-A |
Report |
Oct 15, 2015 |
5419 |
| Celecoxib safety study may soothe cardio concerns. |
Freeman, Sara |
|
Sep 15, 2015 |
1009 |
| Pharmacological intravitreal treatment for macular edema in branch retinal vein occlusion--three-month results/Farmakolosko intravitrealno lecenje edema makule kod okluzije grane centralne vene retine--tromesecni rezultati. |
Karadzic, Jelena; Kovacevic, Igor; Ljikar, Jelena; Grgic, Zorka; Devecerski, Gordana |
Report |
Sep 1, 2015 |
3864 |
| Metastatic renal cell cancer: summary from ASCO 2015. |
|
Conference notes |
Aug 1, 2015 |
2447 |
| Antimetastatic Effect of Celecoxib/PLGA in a TA3-MTX-R Murine Breast Adenocarcinoma Model/Efecto Antimetastasico de Celecoxib/PLGA en un Modelo Murino de Adenocarcinoma Mamario TA3-MTX-R. |
Roa, Ignacio; Moraga, Jose; Cantin, Mario; Rosas, Carlos; Lemus, David |
|
Jun 1, 2015 |
4340 |
| Alleged pharma campaign to block Avastin for AMD. |
O'Hare, Ryan |
|
Apr 18, 2015 |
619 |
| Devon CCG backs down on Avastin AMD switch. |
O'Hare, Ryan |
Brief article |
Mar 21, 2015 |
231 |
| Commissioners renew call to use Avastin for AMD patients. |
O'Hare, Ryan |
Brief article |
Mar 7, 2015 |
212 |
| European Medicines Agency's Committee for Medicinal Products for Human Use offers positive recommendation for Roche's Avastin. |
|
|
Mar 3, 2015 |
163 |
| European Medicines Agency's Committee for Medicinal Products for Human Use offers positive recommendation for Roche's Avastin. |
|
|
Mar 3, 2015 |
159 |
| Avastin replaces laser therapy for treatment of diabetic retinopathy in eye patients: Dr. Mustafa. |
|
|
Feb 10, 2015 |
555 |
| Doha-based team in cancer research breakthrough. |
|
|
Jan 15, 2015 |
448 |
| Genistein disrupts glucocorticoid receptor signaling in human uterine endometrial Ishikawa cells. |
Whirledge, Shannon; Senbanjo, Linda T.; Cidlowski, John A. |
Report |
Jan 1, 2015 |
7031 |
| Optimization and characterization of hydroxyapatite nanoparticles loaded with sorafenib tosylate. |
Dileep, K.J.; Ramachandran, Rajesh; Nair, C.R. Sudhakaran |
|
Jan 1, 2015 |
3402 |
| CHANGES IN MACULAR THICKNESS AND VISUAL ACUITY AFTER INTRAVITREAL BEVACIZUMAB INJECTION IN PATIENTS WITH RETINAL VEIN OCCLUSION. |
|
Clinical report |
Dec 31, 2014 |
2464 |
| Intravitreal injection of Bevacizumab in diabetic macular edema. |
|
Report |
Dec 31, 2014 |
2741 |
| New Avastin option. |
|
|
Dec 8, 2014 |
117 |
| Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib. |
Richter, Suzanne; Seah, Jo-An; Pond, Gregory R.; Gan, Hui K.; Mackenzie, Mary J.; Hotte, Sebastien J |
Report |
Dec 1, 2014 |
3362 |
| The United States Food and Drug Administration approves Avastin to treat women with platinum-resistant, recurrent ovarian cancer. |
|
|
Nov 18, 2014 |
169 |
| The United States Food and Drug Administration approves Avastin to treat women with platinum-resistant, recurrent ovarian cancer. |
|
|
Nov 18, 2014 |
167 |
| The United States Food and Drug Administration approves Avastin to treat women with platinum-resistant, recurrent ovarian cancer. |
|
|
Nov 18, 2014 |
163 |
| Annie forced to rent in London because of Wales' 'cruel' ruling. |
|
|
Nov 9, 2014 |
361 |
| 'To be denied drug that has positive effect on my health is devastating'. |
|
|
Oct 27, 2014 |
749 |
| Breckenridge Pharmaceutica files ANDA with Paragraph IV certification for Everolimus. |
|
|
Sep 9, 2014 |
132 |
| Breckenridge Pharmaceutica files ANDA with Paragraph IV certification for Everolimus. |
|
|
Sep 9, 2014 |
128 |
| Roche gains European approval for Avastin ovarian cancer treatment. |
|
|
Aug 7, 2014 |
202 |
| Roche gains European approval for Avastin ovarian cancer treatment. |
|
|
Aug 7, 2014 |
198 |
| My husband got 8 months of life from drug they won't give to Reece, 21; NHS 'should fund this treatment'; EXCLUSIVE. |
|
|
Jul 30, 2014 |
412 |
| My husband got 8 months of life from drug they won't give to Reece, 21; 'Health chiefs should fund him'; EXCLUSIVE. |
|
|
Jul 30, 2014 |
410 |
| My husband got 8 months of life from drug they won't give to Reece, 21; NHS 'should fund this treatment'. |
|
|
Jul 30, 2014 |
412 |
| The NHS pays for cosmetic surgery and gastric bands but it won't save me... there should be no price put on health; CRISIS IN OUR HEALTH SERVICE: 21-YEAR-OLD'S CANCER FIGHT. |
|
|
Jul 29, 2014 |
908 |
| US Food and Drug Administration accepts supplemental Biologics License Application for Avastin and offers Priority Review. |
|
|
Jul 24, 2014 |
152 |
| US Food and Drug Administration accepts supplemental Biologics License Application for Avastin and offers Priority Review. |
|
|
Jul 24, 2014 |
148 |
| To study and compare the efficacy and safety of intravitreal bevacizumab and intravitreal triamcinolone acetonide for the treatment of diabetic macular edema. |
Kumar, Jitendra; Misuriya, V.K.; Sonkar, Sujeet Kumar |
|
Jun 30, 2014 |
2627 |
| Cancer patient's live to meet my plea: 'Help me first grandchild'. |
|
|
May 10, 2014 |
1185 |
| Morphological effects of genistein, thymoquinone, 5-FU, and laser therapy on laryngeal carcinoma cells. |
Adah, Osasu; Wilson, Gerri; Adah, Felix; Tucci, Michelle; Benghuzzi, Hamed |
Report |
Apr 1, 2014 |
2207 |
| Italy fines Swiss pharmaceutical giants for 'illicit deal'. |
|
|
Mar 5, 2014 |
291 |
| Estrogen receptor alpha augments changes in hemostatic gene expression in HepG2 cells treated with estradiol and phytoestrogens. |
Kelly, Lynne A.; Seidlova-Wuttke, Dana; Wuttke, Wolfgang; O'Leary, John J.; Norris, Lucy A. |
Report |
Jan 15, 2014 |
2568 |
| Expression of angiogenesis regulatory proteins and epithelial-mesenchymal transition factors in platelets of the breast cancer patients. |
Han, Hui; Cao, Fang-Li; Wang, Bao-Zhong; Mu, Xue-Ru; Li, Guang-Yao; Wang, Xiu- Wen |
Report |
Jan 1, 2014 |
4745 |
| Age-related macular degeneration: Clinical findings following treatment with antiangiogenic drugs. |
Casaroli-Marano, Ricardo; Gallego-Pinazo, Roberto; Fernandez-Blanco, Clemencia Torron; Figueroa, Mar |
Report |
Jan 1, 2014 |
4827 |
| New drug shows promise for 'triple-negative' breast cancer patients. |
|
|
Dec 14, 2013 |
248 |
| 'I have to rent home in London to get cancer treatment I need' Patient questions why drug wasn't available at Velindre. |
|
|
Nov 2, 2013 |
616 |
| Cancer patient rents flat in London to get treatment on English NHS; 'INJUSTICE' OF DRUG AVASTIN NOT AVAILABLE ON WALES NHS. |
|
|
Nov 2, 2013 |
1482 |
| A VISION OF HOPE; Belfast study proves cancer drug can prevent blindness. |
|
|
Jul 19, 2013 |
361 |
| Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy. |
|
Clinical report |
Jun 30, 2013 |
2061 |
| Efficacy of topical Bevacizumab in high-risk corneal transplant survival. |
|
Clinical report |
Jun 30, 2013 |
2279 |
| A one-year follow-up study of ocular and systemic complications of intravitreal injection of bevacizumab (Avastin). |
|
Clinical report |
Jun 30, 2013 |
2720 |
| Lillya[euro](tm)s Enzastaurin Phase III study did not meet primary endpoint; stops development of Enzastaurin. |
|
Clinical report |
May 13, 2013 |
183 |
| Lillya[euro](tm)s Enzastaurin Phase III study did not meet primary endpoint; stops development of Enzastaurin. |
|
Clinical report |
May 13, 2013 |
179 |
| MEASUREMENT OF INTRAOCULAR PRESSURE FOLLOWING 0.05 ML (1.25MG) INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) TO DETERMINE THE RATIONALE OF USING POST-INJECTION IOP LOWERING MEDICATION. |
|
|
Mar 31, 2013 |
2975 |
| @dailyrecord. |
|
|
Mar 14, 2013 |
188 |
| How dare they put a price on a life when drug would give me valuable extra time? Cancer patient Sharon's fury as experts refuse to fund Avastin. |
|
|
Mar 12, 2013 |
744 |
| Bevacizumab significantly improves survival for patients with recurrent and metastatic cervical cancer. |
|
Report |
Feb 7, 2013 |
110 |
| Avastin misses key data point in brain cancer study. |
|
|
Jan 15, 2013 |
163 |
| Predictors of visual response to intravitreal bevacizumab for treatment of neovascular age-related macular degeneration. |
Fang, Kai; Tian, Jun; Qing, Xueying; Li, Shuai; Hou, Jing; Li, Juan; Yu, Wenzhen; Chen, Dafang; Hu, |
Report |
Jan 1, 2013 |
6560 |
| Silymarin potentiates the anti-inflammatory effects of celecoxib on chemically induced osteoarthritis in rats. |
Ashkavand, Z.; Malekinejad, H.; Amniattalab, A.; Rezaei-Golmisheh, A.; Vishwanath, B.S. |
Report |
Oct 15, 2012 |
5215 |
| Intravitreal bevacizumab for peripapillary subretinal neovascular membrane associated to papilledema: a case report. |
Mas, Alma M.; Villegas, Victor M.; Garcia, Jose M.; Acevedo, Sarah; Serrano, Luis |
Report |
Sep 1, 2012 |
1454 |
| Using Avastin for wet AMD 'could save NHS 84.5m [pounds sterling]'. |
|
Brief article |
May 18, 2012 |
262 |
| Concerns over AMD drug. |
|
Brief article |
May 4, 2012 |
337 |
| Cheap drugs battle a'scandal'. |
|
|
May 3, 2012 |
687 |
| FDA warns of counterfeit anti-cancer drug Avastin [R]. |
Finkel, J. |
Brief article |
May 1, 2012 |
209 |
| Abbott Gets Japan's Approval for XIENCE PRIME Stent. |
|
|
May 1, 2012 |
973 |
| Avastin and Lucentis are equivalent in treating age-related macular degeneration. |
|
|
Apr 30, 2012 |
121 |
| 'You'll do whatever you can to save your life' Woman's fight for cancer drug. |
|
|
Apr 28, 2012 |
779 |
| Avastin rejected by NICE for breast cancer. |
|
|
Apr 18, 2012 |
183 |
| New batch of fake Avastin shipped from UK to US. |
|
|
Apr 4, 2012 |
335 |
| War on cancer. |
Moss, Ralph |
|
Apr 1, 2012 |
2168 |
| India sets precedent for overcoming drug price barriers. |
Bateman, Chris |
|
Apr 1, 2012 |
556 |
| GlaxoSmithKline plc announces FDA's ODAC votes in favour of Pazopanib for certain advanced soft tissue sarcoma. |
|
|
Mar 21, 2012 |
132 |
| Fake Avastin shows very little protects drug supply. |
|
|
Mar 12, 2012 |
1346 |
| Egyptian Middleman bough fake Avastin from Turkey. |
|
|
Feb 29, 2012 |
782 |
| Egyptian middleman bought fake Avastin from Turkey. |
|
|
Feb 29, 2012 |
778 |
| Egyptian firm in fake Avastin scam proves elusive. |
|
|
Feb 22, 2012 |
490 |
| Egyptian firm in fake Avastin scam proves elusive. |
|
|
Feb 22, 2012 |
501 |
| Idera Pharmaceuticals unveils positive data from Phase Ib study of IMO-2055. |
|
Clinical report |
Jan 20, 2012 |
192 |
| BIGGEST CANCER HOPE IN 15 YEARS; Drug to combat ovarian killer. |
|
|
Jan 17, 2012 |
232 |
| Avastin approval for breast cancer treatment revoked by FDA. |
|
|
Jan 1, 2012 |
137 |
| Avastin delays ovarian cancer progression. |
|
|
Dec 29, 2011 |
370 |
| Avastin indication revoked. |
|
|
Dec 12, 2011 |
485 |
| FDA revokes Avastin approval for breast cancer. |
Mechcatie, Elizabeth |
|
Dec 1, 2011 |
615 |
| FDA Approves XIENCE PRIME Drug Eluting Sten. |
|
Company overview |
Dec 1, 2011 |
986 |
| US FDA Commissioner revokes approval of Rochea[euro](tm)s Avastin for treatment of metastatic breast cancer. |
|
|
Nov 18, 2011 |
164 |
| The inflammatory factor underlying most cancers. |
Hoffnung, David |
|
Nov 1, 2011 |
4346 |
| Roche may compensate German clinics for inefficacy cases of Avastin - Sueddeutschen Zeitung. |
|
|
Oct 24, 2011 |
187 |
| Bevacizumab's label adds adverse reactions. |
|
|
Oct 15, 2011 |
350 |
| Report: Avastin slices Medicare costs. |
|
|
Sep 26, 2011 |
101 |
| Japan's govt greenlights additional indication for Roche's Avastin. |
|
|
Sep 26, 2011 |
102 |
| VA department drops Roche's Avastin use for eye disease. |
|
|
Sep 22, 2011 |
138 |
| Anger at drug denial; Widower's fury at decision to withhold cancer treatment. |
|
|
Sep 6, 2011 |
520 |
| US alerts against repackaged injections. |
|
|
Sep 6, 2011 |
396 |
| NICE says no to Rochea[euro](tm)s Avastin but recommends MabThera. |
|
|
Sep 5, 2011 |
158 |
| Erbitux, Avastin and Vectibix fail to secure NICE recommendation for metastatic colorectal cancer. |
|
|
Sep 5, 2011 |
141 |
| Avast Avastin! |
Massion, Charlea T.; Fugh-Berman, Adriane |
|
Sep 1, 2011 |
903 |
| New class of antiangiogenesis drugs identified. |
McBride, Deborah |
Report |
Sep 1, 2011 |
236 |
| 'Soy isoflavone tablets don't prevent bone loss or menopausal symptoms'. |
|
|
Aug 9, 2011 |
248 |
| CMS: medicare will still cover Avastin if FDA alters status. |
|
|
Jul 18, 2011 |
401 |
| Genistein aglycone effect on bone loss is not enhanced by supplemental calcium and vitamin [D.sub.3]: a dose ranging experimental study. |
Bitto, A.; Marini, H.; Burnett, B.P.; Polito, F.; Levy, R.M.; Irrera, N.; Minutoli, L.; Adamo, E.B.; |
Report |
Jul 15, 2011 |
5321 |
| Medicare to pay for Avastin regardless of FDA. |
|
|
Jul 3, 2011 |
205 |
| 01 F.Hoffman-La Roche. |
|
|
Jul 1, 2011 |
2068 |
| FDA Committee recommends withdrawal of approval for Genentech's Avastin in metastatic breast cancer. |
|
|
Jun 30, 2011 |
173 |
| Effect of intravitreal bevacizumab in diabetic macular edema. |
Shaikh, Fahad Feroze; Arain, Aziz-ur-Rehman |
Clinical report |
Jun 30, 2011 |
3335 |
| Compare and contrast: Genentech violates embargo for Lucentis lobbying. |
Silverman, Ed |
|
Jun 1, 2011 |
1528 |
| NIH study finds Avastin and Lucentis are equally effective in treating age-related macular degeneration. |
|
|
Apr 28, 2011 |
115 |
| Dalteparin, unfractionated heparin equal in DVT prevention. |
Moon, Mary Ann |
|
Apr 1, 2011 |
609 |
| Phytoestrogens in menopause. |
van Die, M. Diana |
Clinical report |
Mar 22, 2011 |
5729 |
| Roche says EC backs Avastin plus paclitaxel for metastatic breast cancer. |
|
|
Mar 2, 2011 |
203 |
| FDA grants Genentech hearing on Avastin's use for mBC. |
|
|
Feb 25, 2011 |
128 |
| Genentech's Phase III study of Avastin meets primary endpoint. |
|
|
Feb 8, 2011 |
274 |
| Genentech reports success of Phase III study of Avastin, meeting primary endpoint. |
|
|
Feb 8, 2011 |
279 |
| Genistein for endometrial hyperplasia in premenopausal women. |
Gaby, Alan R. |
Brief article |
Feb 1, 2011 |
182 |
| Women with advanced breast cancer who were treated with Roche Holding AG's (Basel CHE) Avastin were more likely to develop heart failure than other women, according to an analysis released last week that raised more concerns about the already troubled drug. |
|
|
Jan 10, 2011 |
346 |
| Avastin raises heart failure risk. |
|
|
Jan 5, 2011 |
549 |
| Roche Suffers Double Setback with Avastin Cancer Treatment. |
|
|
Dec 20, 2010 |
387 |
| US: Avastin should not be used for breast cancer. |
|
|
Dec 16, 2010 |
196 |
| Breast cancer drug is rejected for NHS use. |
|
|
Dec 8, 2010 |
228 |
| Cancer drug blow; Life-extending treatment too costly for NHS. |
|
|
Nov 12, 2010 |
654 |
| Stunning Avastin reversal. |
Moss, Ralph |
|
Nov 1, 2010 |
2180 |
| Roche announces positive data for Avastin in ovarian cancer. |
|
|
Oct 11, 2010 |
159 |
| Genistein with selenium may arrest prostate cancer cell growth. |
Murphy, Kathleen |
Report |
Sep 22, 2010 |
665 |
| FDA extends review period for Avastin approval in advanced HER2-negative breast cancer. |
|
|
Sep 20, 2010 |
236 |
| Roche's Avastin misses primary endpoint in early-stage colon cancer. |
|
|
Sep 20, 2010 |
190 |
| Isoflavones isolated from red clover (Trifolium pratense) inhibit smooth muscle contraction of the isolated rat prostate gland. |
Brandli, A.; Simpson, J.S.; Ventura, S. |
Report |
Sep 1, 2010 |
5231 |
| Disappointment as regulator rejects bowel cancer drug. |
|
|
Aug 24, 2010 |
566 |
| Cancer drug turned down by watchdog; Campaigners disappointed at decision. |
|
|
Aug 24, 2010 |
362 |
| Cancer drug is denied. |
|
|
Aug 24, 2010 |
127 |
| Anger as Avastin is rejected by Nice; NHS WILL NOT GIVE BREAST CANCER DRUG. |
|
|
Jul 9, 2010 |
420 |
| Genentech announces Avastin-Containing Regimen helped ovarian cancer women live longer. |
|
|
Jul 2, 2010 |
236 |
| Genentech reports longer survival rate of ovarian cancer from second Phase III study of Avastin. |
|
|
Jul 2, 2010 |
233 |
| Roche&'s Avastin helps slow ovarian cancer progression. |
|
|
Jul 2, 2010 |
360 |
| Bevacizumab plus chemo ups ovarian cancer survival. |
Osterweil, Neil |
|
Jul 1, 2010 |
479 |
| Journal abstracts: the key importance of soy isoflavone bioavailability to understanding health benefits. |
|
Report |
Jul 1, 2010 |
171 |
| Celecoxib may offset aspirin's heart benefits. |
|
|
Apr 1, 2010 |
115 |
| Widow campaigns to end drugs lottery; Mum's fight for treatment to prolong life. |
|
|
Mar 25, 2010 |
602 |
| Genentech announces data from Phase III study of Avastin. |
|
|
Mar 12, 2010 |
229 |
